Cargando…

PB2098: ‘REAL-WORLD’ TREATMENT PATTERNS AND PATHWAYS OF SECOND LINE DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS IN UK, CANADA, FRANCE, GERMANY, ITALY AND SPAIN USING A PROSPECTIVE SURVEY OF PHYSICIANS

Detalles Bibliográficos
Autores principales:	Bailey, A., Milloy, N., Sanderson, I., Butcher, J., Spooner, C., Kilic, D., Vadgama, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431557/ http://dx.doi.org/10.1097/01.HS9.0000851224.51567.a8

Ejemplares similares

PB2199: GEOGRAPHIC CLUSTERING OF ERDHEIM-CHESTER DISEASE IN ITALY AND FRANCE
por: Peyronel, Francesco, et al.
Publicado: (2023)

Data on Income inequality in Germany, France, Italy, Spain, the UK, and other affluent nations, 2012
por: Dorling, Danny
Publicado: (2015)

The Incidence, Prevalence, and Mortality of Stroke in France, Germany, Italy, Spain, the UK, and the US: A Literature Review
por: Zhang, Younan, et al.
Publicado: (2012)

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2013)

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study
por: Wang, Ting, et al.
Publicado: (2020)

Modelling the initial epidemic trends of COVID-19 in Italy, Spain, Germany, and France
por: Wang, Kai, et al.
Publicado: (2020)

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
por: Tran, Trung N., et al.
Publicado: (2020)

PROJECT ADMINISTRATION AGREEMENT KN2098/EN
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2012)

PB2203: INCIDENCE AND PREVALENCE OF MYELOFIBROSIS IN GERMANY: A RETROSPECTIVE CLAIMS DATA ANALYSIS
por: Junker, Sophia, et al.
Publicado: (2023)

The Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1859)

Health, social and legal supports for migrant agricultural workers in France, Italy, Spain, Germany, Canada, Australia and New Zealand: a scoping review
por: Caxaj, C. Susana, et al.
Publicado: (2023)

PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN SPAIN
por: Boqué, Concepción, et al.
Publicado: (2023)

PB2511: CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN GERMANY
por: Udeze, Chuka, et al.
Publicado: (2023)

PB2421: EPSTEIN-BARR VIRUS-ASSOCIATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE: RESULTS OF A DELPHI STUDY IN SPAIN.
por: Sureda, Anna, et al.
Publicado: (2023)

PB2137: SOCIO-DEMOGRAPHIC FEATURES AND TREATMENT PATTERNS OF MULTIPLE MYELOMA PATIENTS IN SPAIN: AN INTERIM ANALYSIS OF DORIANT STUDY
por: Montes-Gaisán, Carmen, et al.
Publicado: (2023)

PB2628: EXPERIENCE AT THE GUADALAJARA UNIVERSITY HOSPITAL (SPAIN) IN FETAL AND NEONATAL ALLOINMUNE THROMBOCYTOPENIA (FNAIT) DURING EIGHT YEARS.
por: López, María Irene Nuevo, et al.
Publicado: (2023)

Future of renewable energy consumption in France, Germany, Italy, Spain, Turkey and UK by 2030 using optimized fractional nonlinear grey Bernoulli model
por: Şahin, Utkucan
Publicado: (2021)

PB1755: CLINICAL FEATURES AND BIOLOGICAL CHARACTERIZATION OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED IN A REGIONAL HOSPITAL IN FRANCE
por: Dutari, Pilar, et al.
Publicado: (2023)

PB2044: TRIAL IN PROGRESS: OBSERVATIONAL STUDY IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED IN ITALY WITH MIDOSTAURIN (OVIDIO)
por: Grifoni, F. I., et al.
Publicado: (2022)

The Asylums of Italy, Germany, and France, &c.
por: Arlidge, J. T.
Publicado: (1858)

Notes on the Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1860)

PB2525: A FOUR YEARS’ EXPERIENCE OF UNIVERSAL NEWBORN SCREENING FOR HAEMOGLOBIN DISORDERS IN UDINE, FVG, NORTHERN ITALY
por: Cmet, Sara, et al.
Publicado: (2023)

PB2238: ΒETA-THALASSEMIA INTERMEDIA: INTERACTION OF ΑLPHA-GLOBIN GENE TRIPLICATION WITH ΒETA-THALASSEMIA HETEROZYGOUS IN SPAIN
por: Ropero, P., et al.
Publicado: (2022)

PB2105: REAL WORLD EXPERIENCE WITH POLATUZUMAB IN COMBINATION WITH BENDAMUSTINE AND RITUXIMAB FOR R/R DLBCL IN 3 ACADEMIC CENTERS IN MADRID, SPAIN.
por: Corrochano, M., et al.
Publicado: (2022)

Ten-Year Trends in Sales of Alzheimer Disease Drugs in France Compared With Sales in Germany, Spain, and the UK
por: Ben Hassen, Céline, et al.
Publicado: (2022)

P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
por: Ramasamy, Karthik, et al.
Publicado: (2023)

COVID-19 and Territorial Policy Dynamics in Western Europe: Comparing France, Spain, Italy, Germany, and the United Kingdom
por: Vampa, Davide
Publicado: (2021)

EU Member States’ Institutional Twitter Campaigns on COVID-19 Vaccination: Analyses of Germany, Spain, France and Italy
por: Tuñón Navarro, Jorge, et al.
Publicado: (2023)

Draft Genome Sequence of Mycobacterium peregrinum Strain CSUR P2098
por: Asmar, Shady, et al.
Publicado: (2015)

2098. Applying Antimicrobial Consumption Metrics to Characterize Inpatient Stewardship Opportunities
por: Bohn, Brian C, et al.
Publicado: (2019)

PB2330: PERIPHERAL T CELL LYMPHOMAS TREATED WITH SYSTEMIC CHEMOTHERAPY, CLINIC CHARACTERISTICS AND RESULTS AFTER TREATMENT: REAL LIFE STUDY IN A TERTIARY CARE HOSPITAL IN SPAIN
por: Garcia, Daniel, et al.
Publicado: (2023)

Estimation of COVID-19 prevalence in Italy, Spain, and France
por: Ceylan, Zeynep
Publicado: (2020)

PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER INDUCTION CHEMOTHERAPY
por: Raffoux, E., et al.
Publicado: (2022)

Mr. Lee on the Medical Institutions of France, Germany, and Italy
Publicado: (1836)

PB1786: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN LEUKAEMIAS: THE EXPERIENCE OF THE CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK
por: Muraru, M., et al.
Publicado: (2022)

Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
por: Tarantola, Alice, et al.
Publicado: (2023)

PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK
por: Muraru, Mariela, et al.
Publicado: (2023)

PB2100: REAL-WORLD TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A RETROSPECTIVE CHART STUDY
por: Guillaume, Xavier, et al.
Publicado: (2023)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

PB1952: CLL IN AYA
por: Mohamed, Shehab, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b61sc2qnd2nmpdh3sskubu8qq8